Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
12 Patents
#5 in Altrincham
#1,460 in United Kingdom
#48,209 in the World
Centessa Pharmaceuticals (UK) Limited
Forward Citations = 0
15 inventors:
Centessa Pharmaceuticals (UK) Limited
Trademarks = 1
Forward Citations = 0
Loading Chart...
Loading Chart...
15 inventors (with patents filed for the assignee):
Nigel Ramsden (7 out of 8 patents)
David John Fox (7 out of 20 patents)
James Andrew Huntington (7 out of 8 patents)
4. James Michael Tomlinson (4 out of 4 patents)
5. Paul Humphries (2 out of 8 patents)
6. Wojciech Zawodny (2 out of 2 patents)
7. William James Jonathan Finlay (2 out of 2 patents)
8. Karl Gibson (2 out of 2 patents)
9. Matthew Spendiff (2 out of 2 patents)
10. John Andrew Christopher (1 out of 24 patents)
11. Gordon Saxty (1 out of 42 patents)
12. Roderick Alan Porter (1 out of 2 patents)
13. Steve Holmes (1 out of 5 patents)
14. Bruce Lefker (1 out of 1 patent)
15. Sarah Bucknell (1 out of 1 patent)
12 patents:
1. 12679804 - 2-(3-ethynylbenzyl)-substituted heterocycle derivatives and related uses (2026-07-14),
2. 12673050 - Compositions and their use for the treatment of A1-antitrypsin deficiency (2026-07-07),
4. 12611402 - Compounds and their use for the treatment of ALPHA1-antitrypsin deficiency (2026-04-28),
8. 12365672 - Compounds and their use for the treatment of alpha1-antitrypsin deficiency (2025-07-22),
9. 12291507 - Compounds and their use for the treatment of ALPHA1-antitrypsin deficiency (2025-05-06),
Company Overview
Centessa Pharmaceuticals (UK) Limited is a biopharmaceutical company based in Altrincham, UK, focused on developing innovative therapies for patients with serious diseases. The company leverages a unique asset-centric model, integrating diverse scientific expertise and advanced technologies to accelerate drug discovery and development. Centessa specializes in various therapeutic areas, including oncology and rare diseases, aiming to address unmet medical needs through its proprietary pipeline of drug candidates.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Centessa Pharmaceuticals (UK) Limited. Retrieved from https://idiyas.com/company/centessa-pharmaceuticals-uk
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]